Amgen Joins With Community Oncology Networks For New Research Collaboration

Amgen Community Oncology Research Collaborators (ACORC) Will Work to Expand Clinical Trial Access to Cancer Patients Treated Outside of Academic Centers First Members Include US Oncology Research and TRIO-US With UCLA THOUSAND OAKS, Calif., May 28, 2019 /PRNewswire/ -- Amgen (NASDAQ: AMGN), along with leading community oncology networks, today announced the launch of Amgen Community Oncology Research Collaborators (ACORC), a new initiative to enhance access by community centers to innovative oncology clinical research. Fewer than one in 20 adult cancer patients in the U.S. have participated in a clinical trial.1 The collaboration will allow Amgen to significantly expand its clinical r...
Source: Amgen News Release - Category: Pharmaceuticals Tags: Uncategorized Source Type: news